Pharma Published on March 19, 2020 Pharmascience Inc. bring to market a new product for the maintenance treatment of asthma and COPD. Read more on News Wire
Biotech Published on March 19, 2020 IMV Inc., a clinical-stage biopharmaceutical company, announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Vaccines against infectious disease have been a core part of IMV’s heritage across its DPX platform technology. Read more on IMV Inc.
R&D Published on March 15, 2020 At the end of the most recent Canadian Institutes of Health Research (CIHR) competition, 15 projects led by 14 researchers from the Centre de recherche du CHU de Québec-Université Laval were awarded grants totalling close to $9 million. Read more on Quebec CHU - Laval University
R&D Published on March 15, 2020 A team from the Université de Sherbrooke’s Faculty of Medicine and Health Sciences, in close collaboration with the University of Alberta and the University of Toronto, have developed a new pharmacological approach that stimulates muscle stem cells, helping to significantly slow the progression of muscular dystrophy. Read more on Sherbrooke University (UDES)
Business environment Published on March 15, 2020 These two Quebec universities are among the top 200 in the world: McGill University ranks 35th and the Université de Montréal (UdeM) ranks 137th. Read more on Narcity
Genomic & data Published on March 15, 2020 Le Centre universitaire de santé McGill (CUSM) et son Institut de recherche (IR-CUSM) sont heureux d’annoncer que l’équipe de recherche de la Dre Lucy Gilbert recevra une subvention PPAG (Programme de partenariats pour les applications de la génomique) de 6,24 millions de dollars pour finaliser le développement de DOvEEgene (Detecting Ovarian and Endometrial cancers Early using genomics) – un test de dépistage qui pourrait sauver des milliers de vies chaque année au Canada et des millions de vies dans le monde. Read more on Université McGill
R&D Published on March 15, 2020 At 44 years of age, Mike Sapieha is recognized as one of the world’s leading vision health researchers. His discovery of the causes of diabetic retinopathy, a disease of the retina, has earned him international recognition. Read more on Radio-Canada (Santé)
Biotech Published on March 15, 2020 Organoids, miniature copies of tumours or organs developed at the Montreal General Hospital (MGH) from the tumour cells of patients undergoing surgery, could revolutionize personalized medicine. Read more on Québec Science
R&D Published on March 15, 2020 A new molecule being tested at the Centre hospitalier de l’Université de Montréal (CHUM) is a “breakthrough” in the treatment of stroke. Read more on La Presse